Antimicrobial susceptibility of Brucella melitensis isolates in Peru

Antimicrob Agents Chemother. 2011 Mar;55(3):1279-81. doi: 10.1128/AAC.00979-10. Epub 2011 Jan 3.

Abstract

Brucellosis is an important public health problem in Peru. We evaluated 48 human Brucella melitensis biotype 1 strains from Peru between 2000 and 2006. MICs of isolates to doxycycline, azithromycin, gentamicin, rifampin, ciprofloxacin, and trimethoprim-sulfamethoxazole were determined by the Etest method. All isolates were sensitive to tested drugs during the periods of testing. Relapses did not appear to be related to drug resistance.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Azithromycin / pharmacology
  • Brucella melitensis / drug effects*
  • Brucellosis / microbiology
  • Ciprofloxacin / pharmacology
  • Doxycycline / pharmacology
  • Gentamicins / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Peru
  • Rifampin / pharmacology
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology

Substances

  • Anti-Infective Agents
  • Gentamicins
  • Ciprofloxacin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Azithromycin
  • Doxycycline
  • Rifampin